| A simple protein-based surrogate neutralization assay for SARS-CoV-2 KT Abe, Z Li, R Samson, P Samavarchi-Tehrani, EJ Valcourt, H Wood, ... JCI insight 5 (19), 2020 | 207 | 2020 |
| Proximity dependent biotinylation: key enzymes and adaptation to proteomics approaches P Samavarchi-Tehrani, R Samson, AC Gingras Molecular & Cellular Proteomics 19 (5), 757-773, 2020 | 192 | 2020 |
| A SARS-CoV-2–host proximity interactome P Samavarchi-Tehrani, H Abdouni, JDR Knight, A Astori, R Samson, ... BioRxiv, 2020.09. 03.282103, 2020 | 95 | 2020 |
| Neutralization against Omicron variant in transplant recipients after three doses of mRNA vaccine D Kumar, Q Hu, R Samson, VH Ferreira, VG Hall, M Ierullo, ... American Journal of Transplantation 22 (8), 2089-2093, 2022 | 78 | 2022 |
| Neutralization of SARS-CoV-2 variants in transplant recipients after two and three doses of mRNA-1273 vaccine: secondary analysis of a randomized trial D Kumar, VH Ferreira, VG Hall, Q Hu, R Samson, T Ku, M Ierullo, ... Annals of Internal Medicine 175 (2), 226-233, 2022 | 57 | 2022 |
| Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases RM Dayam, JC Law, RL Goetgebuer, GYC Chao, KT Abe, M Sutton, ... JCI insight 7 (11), 2022 | 50 | 2022 |
| A versatile lentiviral delivery toolkit for proximity-dependent biotinylation in diverse cell types P Samavarchi-Tehrani, H Abdouni, R Samson, AC Gingras Molecular & Cellular Proteomics 17 (11), 2256-2269, 2018 | 45 | 2018 |
| Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B J Liu, P Budylowski, R Samson, BD Griffin, G Babuadze, B Rathod, ... Science advances 8 (3), eabj9815, 2022 | 41 | 2022 |
| Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers KT Abe, Q Hu, M Mozafarihashjin, R Samson, K Manguiat, A Robinson, ... medRxiv, 2021.08. 06.21261721, 2021 | 37 | 2021 |
| RNA-binding proteins that lack canonical RNA-binding domains are rarely sequence-specific D Ray, KU Laverty, A Jolma, K Nie, R Samson, SE Pour, CL Tam, ... Scientific Reports 13 (1), 5238, 2023 | 33 | 2023 |
| Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry T Azad, R Singaravelu, Z Taha, TR Jamieson, S Boulton, MJF Crupi, ... Molecular Therapy 29 (6), 1984-2000, 2021 | 28 | 2021 |
| A simple protein-based surrogate neutralization assay for SARS-CoV-2. JCI Insight 5: e142362 KT Abe, Z Li, R Samson, P Samavarchi-Tehrani, EJ Valcourt, H Wood, ... | 26 | 2020 |
| Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings VH Ferreira, JT Solera, Q Hu, VG Hall, BG Arbol, W Rod Hardy, R Samson, ... Nature Communications 13 (1), 4489, 2022 | 20 | 2022 |
| Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers. medRxiv. 2021 KT Abe, Q Hu, M Mozafarihashjin, R Samson, K Manguiat, A Robinson, ... Epub Sep 2, 2021 | 12 | 2021 |
| SARS-CoV-2 virus-like particle neutralizing capacity in blood donors depends on serological profile and donor-declared SARS-CoV-2 vaccination history SJ Drews, Q Hu, R Samson, KT Abe, B Rathod, K Colwill, AC Gingras, ... Microbiology Spectrum 10 (1), e02262-21, 2022 | 11 | 2022 |
| A simple protein-based SARS-CoV-2 surrogate neutralization assay KT Abe, Z Li, R Samson, P Samavarchi-Tehrani, EJ Valcourt, H Wood, ... | 11 | 2020 |
| Utilization of the Abbott SARS-CoV-2 IgG II quant assay to identify high-titer anti-SARS-CoV-2 neutralizing plasma against wild-type and variant SARS-CoV-2 viruses YCJ Lin, DH Evans, NF Robbins, G Orjuela, Q Hu, R Samson, KT Abe, ... Microbiology Spectrum 10 (5), e02811-22, 2022 | 8 | 2022 |
| Resistance of SARS‐CoV‐2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020 SJ Drews, KT Abe, Q Hu, R Samson, AC Gingras, K Colwill, B Rathod, ... Transfusion 62 (1), 37-43, 2022 | 7 | 2022 |
| Phase I randomized, observer-blinded, placebo-controlled study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B N Martin-Orozco, N Vale, A Mihic, T Amor, L Reiter, Y Arita, R Samson, ... Scientific Reports 13 (1), 8557, 2023 | 5 | 2023 |
| A SARS-CoV-2–host proximity interactome. bioRxiv 2020 P Samavarchi-Tehrani, H Abdouni, JDR Knight, A Astori, R Samson, ... Preprint, 0 | 5 | |
anne-claude gingrasLunenfeld-Tanenbaum Research Institute; University of Toronto在 lunenfeld.ca 的电子邮件经过验证
